Profiel
Rachel Meyers is the founder of Faze Medicines, Inc. She is currently an Independent Director at Korro Bio, Inc. since 2023.
Previously, she worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. from 1993 to 2003.
Additionally, she held the position of Vice President-Research & RNAi Lead Discovery at Alnylam Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Meyers obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brandeis University.
Actieve functies van Rachel Meyers
Bedrijven | Functie | Begin |
---|
Eerdere bekende functies van Rachel Meyers
Bedrijven | Functie | Einde |
---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2003 |
Faze Medicines, Inc. | Oprichter | - |
ALNYLAM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Rachel Meyers
Massachusetts Institute of Technology | Doctorate Degree |
Brandeis University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Faze Medicines, Inc. |